Randomised trial comparing biweekly oxaliplatin plus oral capecitabine versus oxaliplatin plus i.v. bolus fluorouracil/leucovorin in metastatic colorectal cancer patients: results of the Southern Italy Cooperative Oncology study 0401.
about
Incidence and relative risk of grade 3 and 4 diarrhoea in patients treated with capecitabine or 5-fluorouracil: a meta-analysis of published trialsA multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer.Oral fluoropyrimidine versus intravenous 5-fluorouracil for the treatment of advanced gastric and colorectal cancer: meta-analysis.XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results.Capecitabine plus oxaliplatin compared with 5-fluorouracil plus oxaliplatin in metastatic colorectal cancer: Meta-analysis of randomized controlled trials.Comparing the effectiveness of capecitabine versus 5-fluorouracil/leucovorin therapy for elderly Taiwanese stage III colorectal cancer patients based on quality-of-life measures (QLQ-C30 and QLQ-CR38) and a new cost assessment tool.Role of oxaliplatin in the treatment of colorectal cancerMulticentric survey on dose reduction/interruption of cancer drug therapy in 12.472 patients: indicators of suspected adverse reactions.Capecitabine for locally advanced and metastatic colorectal cancer: A review.Should capecitabine replace 5-fluorouracil in the first-line treatment of metastatic colorectal cancer?Oral versus intravenous fluoropyrimidines for colorectal cancer.Utilization of capecitabine plus oxaliplatin and 5-fluorouracil/folinic acid plus oxaliplatin in the adjuvant treatment of stage IIB and stage III colon cancer: A multi-centre, retrospective, chart review study.A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy.Baseline physical functioning status of metastatic colorectal cancer patients predicts the overall survival but not the activity of a front-line oxaliplatin-fluoropyrimidine doublet.
P2860
Q27028095-2A63C43B-7C24-4CA8-9900-75E5088E155BQ33413350-B672EE5D-C912-43AA-9CEC-EC12FBAF3B57Q33442681-CD6206D4-124A-43C4-A36A-EE8863AC6756Q34630237-F472E76C-3CBD-448B-AE73-DAD8498E081FQ34639725-01602B8E-80F1-4B41-AA0B-2BF1A091B219Q35663058-B1D9D09A-61E7-44C9-A31B-2831252CC234Q37230238-79D45142-88BD-481B-BAB4-B7489D418F26Q37458009-94CEA78F-B37A-4B79-8736-8F927757A20CQ37821286-3AB77264-A5A5-417F-99C0-D631E1ADB2E8Q38216008-23A8787D-8C2E-431C-96C5-7B9CE32341DCQ38650502-C6CAC387-590C-4B18-937F-AFB54DC451FEQ39438479-53F3356B-ECB3-40C6-A0F3-870194C47EE1Q42770955-45E065DB-D54A-40A1-8DEA-C691FE198A2BQ43184602-C9AC96E5-62D9-472A-8683-46193123230F
P2860
Randomised trial comparing biweekly oxaliplatin plus oral capecitabine versus oxaliplatin plus i.v. bolus fluorouracil/leucovorin in metastatic colorectal cancer patients: results of the Southern Italy Cooperative Oncology study 0401.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Randomised trial comparing biw ...... operative Oncology study 0401.
@en
Randomised trial comparing biw ...... operative Oncology study 0401.
@nl
type
label
Randomised trial comparing biw ...... operative Oncology study 0401.
@en
Randomised trial comparing biw ...... operative Oncology study 0401.
@nl
prefLabel
Randomised trial comparing biw ...... operative Oncology study 0401.
@en
Randomised trial comparing biw ...... operative Oncology study 0401.
@nl
P2093
P1476
Randomised trial comparing biw ...... operative Oncology study 0401.
@en
P2093
Antonio Farris
Bruno Massidda
Donato Natale
Gianfranco Filippelli
Giovanni Condemi
Giuseppe Barberis
Luigi Maiorino
Michele Cannone
Pasquale Comella
Sergio Palmeri
P2888
P304
P356
10.1007/S00432-008-0454-7
P577
2008-08-22T00:00:00Z